Business description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Headquartered in Leiden, Netherlands, Pharming focuses on developing and commercializing innovative protein replacement therapies and precision medicines. Their flagship product, RUCONEST, is used to treat acute hereditary angioedema (HAE) attacks. Pharming is also advancing Joenja (leniolisib), an oral small molecule PI3Kδ inhibitor for treating activated phosphoinositide 3-kinase delta syndrome (APDS).
Management board & Supervisory board
| CEO |
| - |
| Management board |
| - |
| Supervisory board |
| - |
Company data
| Name: |
Pharming Group NV |
| Address: |
Vondellaan 47,Leiden |
| Phone: |
- |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
Pharming Group N.V. |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
- |
Investor relations
| Name: |
- |
| IR phone: |
- |
| IR Fax: |
- |
| IR e-mail: |
-
|
